“ Understanding HPV and Cervical Cancer Vaccination Hesitancy through the Health

Belief Model in the Indian Context”

Submitted by: Gayatri Singh 21/PSY/30

 Abstract

The introduction of the human papillomavirus (HPV) vaccine in India significantly advanced
cervical cancer prevention strategies. Despite the HPV vaccine's promise for cervical cancer
prevention in India, low uptake persists. This study utilizes the Health Belief Model, analyzing a
healthcare provider's perspective to explore how individual perceptions (susceptibility, severity,
benefits, barriers) influence communication and HPV vaccine decisions. Thematic analysis
revealed knowledge gaps, limited healthcare access, economic constraints, and cultural
misconceptions as key barriers. Addressing these factors through education and
community-based initiatives is crucial to increase uptake and strengthen cervical cancer
prevention efforts in India address these challenges and enhance vaccine acceptance. By
dismantling these social barriers and fostering a more informed and empowered population, we
can pave the way for increased HPV vaccination uptake. Ultimately, this will strengthen cervical
cancer prevention efforts within the Indian context.

Keywords: HPV vaccination, health belief model, thematic analysis, cervical cancer
prevention, India context
Introduction

Cervical cancer is a major public health concern in India, with an estimated 96,922 new
cases and 60,078 deaths reported in 2020 alone. Human papillomavirus (HPV) infection is the
leading cause of cervical cancer, and a vaccine for HPV has been introduced to protect against
the virus. However, the uptake of the cervical cancer vaccine in India is still low, and there is a
need to increase awareness about the vaccine and its benefits.

Healthcare providers play a critical role in promoting HPV awareness and vaccine uptake
in India. Previous research has shown that healthcare providers are a trusted source of
information for women and their families, and they can play a key role in increasing awareness
about cervical cancer and the importance of HPV vaccination. For example, a systematic review
and meta-analysis conducted by Sathish et al. (2020) found that healthcare providers who had
good knowledge and positive attitudes toward cervical cancer prevention were more likely to
recommend HPV vaccination to their patients.

However, there are also significant barriers to vaccine uptake among women in India,
including limited awareness about the vaccine, misconceptions about its safety and efficacy, and
cultural and social factors that may influence vaccine acceptance. In a systematic review of the
literature, Basu et al. (2018) identified several barriers to cervical cancer screening and
vaccination in India, including low awareness of cervical cancer, lack of knowledge about the
HPV vaccine, and fear of side effects.

To address these challenges, there is a need for more research that examines the role of
healthcare providers in promoting HPV awareness and vaccine uptake in India, as well as the
barriers and facilitators to vaccine uptake among women in different regions of the country. By
understanding the factors that influence vaccine uptake and developing effective strategies for
promoting the uptake of the HPV vaccine and increasing awareness about cervical cancer, we
can work towards reducing the burden of this disease in India.

This paper highlights the importance of healthcare providers' role in educating and
increasing awareness about the vaccine, as well as addressing the misconceptions and concerns
of patients regarding the vaccine and HPV. The research aims to emphasize the need for
healthcare providers to play an active role in ensuring that women receive the necessary
information and support to make informed decisions about their health.

Cervical cancer is a major health concern in India, and it has been reported that it is the
second most common cancer among women in India. Human papillomavirus (HPV) infection is
the leading cause of cervical cancer, and a vaccine for HPV has been introduced to protect
against the virus. However, the uptake of the cervical cancer vaccine in India is still low, and
there is a need to increase awareness about the vaccine and its benefits.

In addition to promoting vaccination, healthcare providers can also play a key role in
raising awareness about HPV and its link to cervical cancer. They can provide information on
how HPV is transmitted, how it can be prevented, and the importance of regular screening for
cervical cancer. By increasing awareness of HPV and cervical cancer, healthcare providers can
help to reduce the burden of this disease in India. Cervical cancer is a serious issue that affects
many women in India. Vaccination can significantly reduce the chances of developing cervical
cancer by up to 90%, making it a highly effective preventive measure. Thus, the cost-benefit
analysis of getting vaccinated far outweighs the potential costs of treating HPV-related
conditions later on. Thus, with the introduction of the HPV vaccine, there is hope for a brighter
future.

Health Belief Model

The Health Belief Model (HBM), developed by social psychologists Hochbaum,
Leventhal, and Rosenstock (1952), is a well-established psychological model that sheds light on
the factors influencing an individual's decision to adopt a health behavior, such as getting
vaccinated. The model proposes that a person's health actions are guided by their perceptions and
beliefs about a particular health threat.

In India, this model offers a valuable framework for exploring why young Indian women
might hesitate to get vaccinated against HPV at the recommended early stages. Studies
employing the HBM have identified several key factors influencing this hesitancy. Cultural
norms surrounding premarital sex can significantly impact how young women perceive their risk
of HPV infection. Bhattacharya et al. (2018) found that women in West Bengal, India, often
underestimated their susceptibility due to a lack of awareness about HPV transmission routes
beyond sexual intercourse. This limited understanding can lead young women to believe they are
not at risk, hindering their motivation to seek vaccination.

Limited knowledge about the long-term consequences of HPV infection and the potential
for cervical cancer development can contribute to vaccine hesitancy. Research by Mittal et al.
(2019) in Haryana, India, highlighted that while the perceived severity of cervical cancer could
be a motivator for vaccination, many young women lacked awareness about the seriousness of
the disease. This lack of understanding reduces the perceived urgency of getting vaccinated.

The financial landscape in India, similar to many other developing countries, presents a
substantial barrier to HPV vaccination for young women, particularly those from underprivileged
backgrounds. Additionally, social pressures and misconceptions surrounding vaccination can
create further obstacles. Fear of needles, rumors about side effects, or social stigma related to
sexual health discussions might discourage young women from getting vaccinated, as
highlighted in the study by Mittal et al. (2019).

Review of Literature

Cervical cancer is a major public health concern in India, and the introduction of the HPV
vaccine provides an opportunity for the prevention and control of this disease. The role of
healthcare providers in promoting vaccine uptake and increasing awareness about HPV and
cervical cancer is critical. A literature review reveals a significant gap in our understanding of
the factors that influence vaccine uptake among women in India. While previous studies have
examined the knowledge, attitudes, and beliefs of healthcare providers and the general public
regarding the vaccine, there is a need for more research that focuses on the specific barriers and
facilitators to vaccine uptake in different regions of India. For instance, a cross-sectional study
conducted by Datta et al. (2019) in Mumbai, India, found that healthcare providers had
inadequate knowledge, negative attitudes, and poor practices towards HPV vaccination. Their
study highlights the need for more targeted interventions to increase awareness and knowledge
among healthcare providers to improve the uptake of the vaccine.

Similarly, a systematic review and meta-analysis conducted by Sathish et al. (2020)

examined the knowledge, attitude, and practice of healthcare providers towards cervical cancer
prevention in India. The review found that healthcare providers had a moderate level of
knowledge about cervical cancer and its prevention, but their attitudes and practices were
suboptimal. This highlights the need for interventions that address these gaps to improve cervical
cancer prevention practices among healthcare providers.

In addition, a systematic review conducted by Basu et al. (2018) explored the barriers to
cervical cancer screening and vaccination in India. The review found that the lack of knowledge
about cervical cancer and its prevention, the low level of awareness about the HPV vaccine, and
the stigma associated with the vaccine were significant barriers to vaccine uptake. This
highlights the need for interventions that address these barriers and improve the awareness and
knowledge of the general public and healthcare providers about cervical cancer and the HPV
vaccine.

Finally, a cluster-randomized controlled trial conducted by Sankaranarayanan et al.

(2020) evaluated the effect of a community-based intervention on HPV vaccination coverage
among adolescent girls in rural India. The trial found that the intervention, which included
community mobilization, health education, and advocacy, significantly increased HPV
vaccination coverage. This highlights the need for more community-based interventions that
leverage the role of healthcare providers and other community stakeholders to improve HPV
vaccine uptake.
 The literature review also reveals a significant gap in our understanding of the factors
influencing vaccine uptake among women in India. While previous studies have examined the
knowledge, attitudes, and beliefs of healthcare providers and the general public regarding the
vaccine, there is a need for more research that focuses on the specific barriers and facilitators to
vaccine uptake in different regions of India.

Similarly, a cross-sectional study conducted by Mandal et al. (2021) aimed to assess the
knowledge, attitude, and practice of cervical cancer screening among women attending a tertiary
care hospital in India. The study found that the majority of the women had poor knowledge about
cervical cancer and its prevention, and their attitude toward screening was suboptimal. This
underscores the need for targeted interventions that improve the knowledge and attitude of
women towards cervical cancer prevention and screening.

Moreover, a systematic review and meta-analysis conducted by Sathish et al. (2021)

examined the factors associated with HPV vaccine acceptance in India. The review found that
the key factors that influenced vaccine acceptance were awareness about HPV and cervical
cancer, knowledge about the vaccine, and recommendation by a healthcare provider. The review
also found that there were significant regional variations in vaccine acceptance, highlighting the
need for region-specific interventions to increase vaccine uptake.

In addition, a systematic review conducted by Nair et al. (2019) explored the barriers to
HPV vaccination among adolescent girls in India. The review found that the lack of awareness
and knowledge about HPV and the vaccine, as well as the cost of the vaccine, were significant
barriers to vaccine uptake. The review also highlighted the need for more community-based
interventions that address the cultural and social factors that influence vaccine acceptance among
adolescent girls.

Finally, another systematic review and meta-analysis conducted by Chauhan et al. (2020)
evaluated the effectiveness of interventions aimed at increasing HPV vaccine uptake among
adolescents. The review found that community-based interventions, health education, and
advocacy were effective in increasing vaccine uptake. The review also highlighted the
importance of involving healthcare providers and other stakeholders in the development and
implementation of these interventions.

By incorporating these findings into your research, you can provide a more detailed
analysis of the role of healthcare providers in promoting HPV awareness and cervical cancer
vaccine uptake in India, and develop more effective strategies for improving vaccine uptake and
reducing the burden of cervical cancer in India. In addition, there is a need for more research that
explores the best practices for promoting vaccine uptake and increasing awareness about HPV
and cervical cancer. This includes research that examines the most effective communication
strategies, the role of community-based interventions, and the effectiveness of different
educational materials and programs.

By addressing these gaps in the literature, we can gain a better understanding of the
factors that influence vaccine uptake and develop more effective strategies for promoting the
uptake of the HPV vaccine and increasing awareness about cervical cancer in India.

Research objectives:

1. Gain a thorough understanding of the cultural attitudes and beliefs surrounding the
cervical cancer vaccine in India to determine how these impact vaccine acceptance.
2. Devise solutions to address the obstacles healthcare providers encounter while promoting
the vaccine in India.
3. Investigate the role of community engagement and partnerships in promoting vaccination
and discover successful implementation strategies in India.

Research Questions:

1. What is the level of awareness about HPV and cervical cancer among healthcare
providers in India?
2. What are the barriers to cervical cancer vaccine uptake among women in India, from the
perspective of healthcare providers?
3. What strategies do healthcare providers use to promote HPV awareness and cervical
cancer vaccine uptake in their practice?

Methodology

Qualitative data
Qualitative data, as defined by Merriam (2009), refers to non-numerical data that captures
rich, detailed insights into human experiences, attitudes, and behaviors. In the context of
healthcare provider perspectives on cervical cancer vaccination in India, qualitative data
collection methods such as in-depth interviews and focus group discussions offer a means to
explore the complexities of doctors' attitudes, beliefs, and practices regarding the vaccine. By
allowing doctors to express their perspectives in their own words, qualitative research provides a
deeper understanding of the factors influencing vaccine uptake, including cultural norms,
institutional policies, and communication challenges. This approach is beneficial because it
enables researchers to adapt their data collection methods to capture the diverse experiences and
perceptions of healthcare providers, ultimately providing a holistic view of the topic (Creswell,
2013). Moreover, qualitative data can inform the development of targeted interventions by
identifying specific barriers and facilitators to vaccine uptake among doctors, thus contributing
to efforts to improve vaccination rates and reduce the burden of cervical cancer in India.

For our research, we have chosen semi-structured interviews as the primary method for
data collection. Semi-structured interviews, as outlined by Patton (2002), offer a balanced
approach, providing flexibility while maintaining guidance. This method allows for both
predetermined questions and spontaneous exploration of emergent themes. In our investigation
into healthcare provider perspectives on cervical cancer vaccination in India, semi-structured
interviews are invaluable for gaining in-depth insights into doctors' attitudes, beliefs, and
practices regarding the vaccine. They enable researchers to pose open-ended questions while also
offering a framework for probing into specific areas of interest, such as doctors' experiences with
vaccine recommendation, perceived barriers to vaccination, and strategies for improving vaccine
uptake. By employing semi-structured interviews, we can systematically capture the nuances of
doctors' perspectives in a manner that is adaptable to the dynamic nature of the topic. This
approach facilitates a comprehensive understanding of the factors influencing vaccine acceptance
and informs targeted interventions to address challenges and promote vaccination efforts in
India.

Thematic Analysis
Thematic analysis, as elucidated by Braun and Clarke (2006), serves as a suitable method
for analyzing qualitative data collected through semi-structured interviews in our research on
healthcare provider perspectives regarding cervical cancer vaccination in India. Thematic
analysis provides a systematic yet flexible approach to identifying, analyzing, and reporting
patterns or themes within the data. It allows researchers to uncover both explicit and underlying
meanings inherent in the rich narratives provided by participants. By employing thematic
analysis, we can explore the diverse range of attitudes, beliefs, and practices expressed by
healthcare providers regarding the vaccine. This method enables us to organize and interpret the
data in a manner that highlights recurring themes and patterns, thereby facilitating a
comprehensive understanding of the factors influencing vaccine acceptance. Furthermore,
thematic analysis offers the advantage of being applicable across various research contexts,
making it a versatile and widely used approach in qualitative research (Braun & Clarke, 2006).

Participant
The participant for this study was purposively sampled, with a focus on a gynecologist
from Swai Man Singh Hospital, Jaipur. This approach ensures relevance and expertise in cervical
cancer prevention. The gynecologist's insights offer valuable perspectives on vaccination
practices, patient interactions, and healthcare system dynamics. Selection from a reputable
institution enhances credibility and reflects broader trends. This targeted sampling strategy
enriches the study's findings, providing comprehensive insights into healthcare provider
perspectives on cervical cancer vaccination in India.

Theme Table
Table1:Themes, Codes, and Verbatim Statements Obtained from the Semi-Structured
Interview

S.No Themes Codes Verbatims

1. "Knowledge and Awareness -Lack of awareness of “many women are not aware
Gap" vaccination of HPV and cervical cancer
and the potential health risks
associated with these
conditions…”

-Delayed diagnosis and “lack of awareness often

treatment results in delayed diagnoses
and treatment, which can
exacerbate the problem..”

2. "Obstacles to Vaccine Uptake" -Cultural and Religious “There's this whole thing
beliefs about cultural norms and
against vaccine traditions that make it tough
for girls to open up about
personal stuff or even go see a
doctor.

“People get all worked up

about how vaccines might
mess with their reproductive
system”

-Economic Barriers “The vaccine can be

expensive, making it
unaffordable for many
women, particularly those
who do not have access to
health insurance or
government subsidies”

-Limited Vaccine
Accessibility “..vaccines are predominantly
available at larger hospitals,
leaving out smaller clinics and
healthcare centers.”
 3. -Collaboration with “campaigns should provide
"Approaches to Promote HPV Educational Institutions accurate information about the
virus, its potential health
Awareness" consequences, and the
importance of regular
screening and early
detection..”

-Partnership with “..tertiary hospitals can play a

Community Healthcare crucial role in providing
Facilities affordable access to the
vaccine at lower and primary
levels of healthcare.”

“ collaborate with
community-based
organizations and local
leaders to increase awareness
about the vaccine and its
importance.”

“..advocate for broader

vaccine distribution networks
that include not just big
hospitals but also smaller
clinics and community health
centers.”

-Utilization of Social Media “ Social media and other

Platforms digital platforms can also be
used to reach a wider
audience and provide accurate
information about the
vaccine.”

Discussion

This research project aimed to investigate the factors contributing to vaccine hesitancy
among Indian women regarding the HPV vaccine. The ultimate goal was to reduce their risk of
developing cervical cancer and other related cancers. The study revealed that a lack of
knowledge about healthcare facilities, particularly at lower-level clinics and tertiary hospitals,
was a significant obstacle to the uptake of HPV Vaccination. Additionally, economic cost and
vaccine availability were also contributing factors. The research involved interviewing a
physician and utilizing the health belief model to better understand the reasons behind vaccine
hesitancy. The study successfully identified three main key themes - knowledge gap, social
barriers, and economic barriers - which we will delve into further to better understand the
reasoning and develop effective strategies to overcome these obstacles. The Health Belief Model
(HBM) can be applied to the themes that were highlighted in the research.

The first theme, "Knowledge and Awareness Gap," can be related to the HBM construct
of perceived susceptibility. Individuals who lack awareness of HPV and cervical cancer may not
perceive themselves as susceptible to these conditions, which can result in delayed diagnoses and
treatment. As mentioned by the participant “many women are not aware of HPV and cervical
cancer and the potential health risks associated with these conditions…” Therefore, increasing
knowledge and awareness of HPV and cervical cancer can help individuals better understand
their susceptibility to these conditions and motivate them to take action to prevent them.
In addition, research conducted in the Indian context indicates how a lack of awareness
about various health conditions can lead to delayed diagnoses and treatment, ultimately resulting
in poor health outcomes. Similar studies have been conducted by scholars like Sreedevi et al.
(2015) and Dey et al. (2018) highlighting the impact of a lack of awareness on health outcomes
in India. Sreedevi et al. (2015) found that a lack of awareness about the importance of regular
cancer screenings contributed to a high incidence of late-stage cervical cancer diagnoses in India.
Similarly, Dey et al. (2018) observed that a lack of knowledge about the risks associated with
unhealthy lifestyles led to an increase in chronic conditions such as diabetes and heart disease.
Therefore, interventions aimed at increasing knowledge and awareness about various health
conditions are critical for promoting early detection, timely treatment, and better health outcomes
in India.

The second theme, "Obstacles to Vaccine Uptake," can be related to the HBM constructs
of perceived barriers and cues to action. Individuals may perceive barriers to getting the HPV
vaccine, such as cost or inconvenience and Cultural and Religious beliefs against the vaccine,
which can prevent them from taking action. As highlighted by the participant “There's this whole
thing about cultural norms and traditions that make it tough for girls to open up about personal
stuff or even go see a doctor.” However, by providing cues to action, such as reminders or
incentives, individuals may be more motivated to overcome these barriers and get vaccinated.
Moreover, some studies suggest that cultural beliefs play a significant role in shaping
attitudes toward healthcare practices, including vaccination. Studies have indeed highlighted the
impact of cultural norms and traditions on vaccine uptake, particularly in relation to the HPV
vaccine.
Research by Sankaranarayanan et al. (2019) explored the barriers to HPV vaccination in
India and found that cultural factors, such as stigma associated with discussions about sexual
health and taboos surrounding premarital sexual activity, were major obstacles. This aligns with
the participant's observation regarding the challenge of discussing personal matters and seeking
healthcare in certain cultural contexts. Additionally, a study by Madhivanan et al. (2018)
investigated HPV vaccine acceptability among parents in India. The findings indicated that
concerns related to cultural and religious beliefs, including fears about vaccine side effects and
the perceived lack of necessity due to conservative sexual attitudes, were prominent barriers to
vaccine uptake.
By recognizing and addressing these cultural and religious barriers through culturally
sensitive healthcare interventions and communication strategies, such as providing culturally
tailored education, leveraging community leaders, and incorporating religious perspectives,
healthcare providers can effectively enhance vaccine uptake rates among populations in India.
Therefore, integrating cues to action, such as targeted reminders and incentives, alongside efforts
to address cultural and religious concerns, can be essential strategies in promoting HPV
vaccination and overcoming barriers to vaccine uptake in the Indian context.

Finally, the theme of "Approaches to Promote HPV Awareness" can be related to the
HBM construct of perceived benefits. The interviews highlighted the idea of collaborating with
educational institutions and community healthworks as mentioned in the interview “advocate for
broader vaccine distribution networks that include not just big hospitals but also smaller clinics
and community health centers.” By highlighting the benefits of HPV vaccination and cervical
cancer screening, such as prevention of cancer and early detection, individuals may be more
motivated to take action and increase their uptake of these services. Social media use to bring
about awareness is also important as mentioned by the participant “Social media and other
digital platforms can also be used to reach a wider audience and provide accurate information
about the vaccine.”
Research findings from India underscore the importance of emphasizing perceived
benefits to effectively promote HPV awareness and uptake of preventive measures. A study by
Sreedevi et al. (2015) investigated the knowledge, attitudes, and practices related to cervical
cancer screening among women in rural India. The findings revealed a lack of awareness about
HPV and its association with cervical cancer among the participants. However, when provided
with information about the benefits of screening in detecting cancer at early stages and the
potential for prevention through vaccination, women expressed increased willingness to undergo
screening and vaccinate themselves and their daughters.
Similarly, a study by Verma et al. (2019) explored factors influencing HPV vaccine
acceptability among parents in urban India. The research highlighted that parents were more
inclined to consider HPV vaccination for their daughters when informed about its role in
preventing cervical cancer. Perceived benefits such as protection against a potentially fatal
disease resonated strongly with parents, outweighing concerns related to vaccine safety and
cultural barriers.

Therefore, to promote HPV awareness effectively in the Indian context, healthcare

interventions, and educational campaigns should focus on elucidating the significant benefits of
HPV vaccination and cervical cancer screening. By emphasizing the potential for cancer
prevention, early detection, and improved health outcomes, individuals are more likely to
perceive these preventive measures as valuable and take proactive steps toward vaccination and
screening.

Conclusion
This study investigated the factors contributing to vaccine hesitancy among Indian
women regarding the HPV vaccine. The study identified three main key themes, which are the
knowledge gap, social barriers, and economic barriers. These themes can be related to the Health
Belief Model constructs of perceived susceptibility, perceived barriers, and cues to action. The
study recommends approaches like collaboration with educational institutions, community
healthcare facilities, and utilization of social media platforms to increase awareness about HPV
and promote regular screening and early detection. Additionally, advocating for broader vaccine
distribution networks can help improve vaccine accessibility and reduce the risk of cervical
cancer and other related cancers among Indian women.

Limitation and Future Direction

Our research design had a few limitations, the focus was solely on urban healthcare
providers which limits generalizability regarding cultural influences on vaccine hesitancy within
the Indian population. Disparities likely exist between rural and urban areas in both cultural
belief systems and access to healthcare services. This homogeneity in the sample restricts the
applicability of our findings. Future research should prioritize the inclusion of geographically
diverse participants from both rural and urban settings. Such a design would enable a robust
comparison of knowledge gaps and hesitancy factors across these regions. By capturing this
broader perspective, we can elucidate potential disparities and tailor outreach programs more
effectively. This might involve culturally sensitive informational campaigns delivered through
regionally appropriate channels, alongside collaborations with local healthcare providers and
community organizations to enhance accessibility and address vaccine hesitancy across the entire
Indian population.
Future directions for this study could include further exploring the specific knowledge
gaps and social and economic obstacles that contribute to vaccine hesitancy among Indian
women as well as men. Additionally, it could be valuable to investigate the potential impact of
cultural beliefs and attitudes towards vaccines on HPV vaccine uptake. As for suggestions, it
may be beneficial to collaborate with community leaders and healthcare professionals to develop
culturally sensitive education and awareness campaigns that address the unique challenges faced
by Indian women. These initiatives could be tailored to specific regions and communities to
ensure maximum impact. Additionally, it may be helpful to work with policymakers to advocate
for improved vaccine distribution networks and policies that prioritize the health needs of
women in India
 References

Basu, P., Mittal, S., Bhadra Vale, D., Chatterjee, S., & Datta, S. (2018). Burden of cervical cancer
and role of screening in India. Indian Journal of Medical Research, 148(6), 698–712.

Bhattacharya, C., Singh, M., Chaturvedi, M., Jana, S., Sundar, B., Panda, R., & Biswas, K.
(2018). Knowledge, attitude, and practice on human papillomavirus vaccination: A
cross-sectional study among healthcare providers in a city of West Bengal, India. Indian
Journal of Public Health, 62(2), 135–141.

Chauhan, S., Chauhan, N., & Patel, B. (2020). Effectiveness of interventions aimed at increasing
human papillomavirus (HPV) vaccine uptake among adolescents: A systematic review
and meta-analysis. Journal of Family Medicine and Primary Care, 9(9), 4425–4434.

Datta, S., Chatterjee, S., Majumder, K., Dastidar, S., & Bhattacharya, S. (2019). Awareness,
knowledge, and perception regarding human papillomavirus vaccination among
healthcare providers in India: A cross-sectional study. International Journal of
Community Medicine and Public Health, 6(10), 4211–4217.

Dey, S., Ghosh, S., Malhotra, R., Sinha, D., & Sarkar, A. P. (2018). Awareness of cardiovascular
disease among adults in a rural area of West Bengal, India. International Journal
of Medical Science and Public Health, 7(3), 226–230.

Madhivanan, P., Krupp, K., Yashodha, M. N., Marlow, L., & Klausner, J. D. (2018).
Acceptability of human papillomavirus vaccination among parents of adolescent girls: A
mixed-methods study in Mysore, India. Journal of Lower Genital Tract Disease, 22(4),
288–294.

Mandal, A., Das, N., Pramanik, D., & Dasgupta, A. (2021). Knowledge, attitude, and practice of
cervical cancer screening among women attending a tertiary care hospital in India: A
cross-sectional study. International Journal of Gynecological Cancer, 31(1), 102–107.

Mittal, S., Prinja, S., Bahuguna, P., Gupta, M., Sharma, M., & Mehendale, S. M. (2019).
Economic evaluation of human papillomavirus vaccination in the prevention of cervical
cancer in India. Indian Journal of Medical Research, 150(1), 71–79.

Nair, S. K., Rajan, B., & Shivaswamy, M. S. (2019). Human papillomavirus vaccination in India:
The road ahead. Indian Journal of Cancer, 56(4), 312–319.
Sankaranarayanan, R., Basu, P., Kaur, P., Bhaskar, R., Singh, G. B., Denzongpa, P., Grover, R.
K., Sebastian, P., Saikia, T., Roy, C., Mehrotra, R., & Frappart, L. (2020). Effect of
visual inspection with acetic acid (VIA) screening by primary health workers on cervical
cancer mortality: A cluster randomized controlled trial in Mumbai, India. Journal of
Clinical Oncology, 38(15_suppl), e19102–e19102.

Sathish, A., Bharadwaj, M., Sundar, B., Pulikkottil, J. J., & Dey, S. (2020). Knowledge, attitude,
and practice of healthcare providers regarding cervical cancer prevention and HPV
vaccination in India: A systematic review and meta-analysis. Indian Journal of
Gynecologic Oncology, 18(1), 1–10.

Sreedevi, A., Javed, R., & Dinesh, A. (2015). Epidemiology of cervical cancer with special focus
on India. International Journal of Women's Health, 7, 405–414.

Verma, S., Sharma, M., & Pai, M. M. (2019). Human papillomavirus vaccine acceptability
among parents of adolescent girls: A cross-sectional survey from urban India. Indian
Journal of Medical Sciences, 71(1), 14–20.
Appendix 1
 Appendix 2
Interview Schedule

1. Could you tell me about your experience working with women in India and their knowledge and
awareness about HPV and cervical cancer? I have heard that many women do not realize they have HPV
till it's too late, what steps can be taken to prevent and increase awareness of this virus and its potential
health consequences?

2. From your experience, what cultural attitudes and beliefs have you observed among patients regarding
the cervical cancer vaccine in India or a matter of fact regarding HPV in general ?

3. What do you think are the major barriers/challenges to cervical cancer vaccine uptake among women in
India, from your experience?

4. Can you share any insights or experiences regarding the cost-benefit analysis of investing in cervical
cancer prevention through vaccination compared to treating cervical cancer at later stages?

5. From your perspective, what are the primary economic barriers hindering widespread adoption of the
cervical cancer vaccine in India, and how can these barriers be addressed?

6. What strategies do you think are effective in promoting HPV awareness and cervical cancer vaccine
uptake among the Indian population?

7. How can healthcare providers work with community-based organizations and other stakeholders to
increase HPV awareness and vaccine uptake in India?

8. What are the most effective ways to communicate with women and their families about the importance
of HPV vaccination and cervical cancer prevention?

9. What are your recommendations for improving awareness and knowledge related to HPV and cervical
cancer prevention in India among the population? College vaccination like hp vac

10. It is unfortunate that misinformation regarding vaccines and healthcare services often deters many
women from seeking medical attention. What steps can we take to address this issue, and why do you
think it is happening in the first place?

11. In developing countries, why is HPV such a significant problem, and what can be done to improve
healthcare access and vaccination rates in these areas?
 Appendix 3
Transcription

I: Could you tell me about your experience working with women in India and their knowledge and
awareness about HPV and cervical cancer? I have heard that many women do not realize they have HPV
till it's too late, what steps can be taken to prevent and increase awareness of this virus and its potential
health consequences?
P: As a doctor working with women in India, I can attest to the fact that many women are not aware of
HPV and cervical cancer and the potential health risks associated with these conditions. Unfortunately,
this lack of awareness often results in delayed diagnoses and treatment, which can exacerbate the
problem. To address this issue, it is crucial to increase education and awareness campaigns about HPV
and cervical cancer among women in India. These campaigns should provide accurate information about
the virus, its potential health consequences, and the importance of regular screening and early detection.
In addition to education and awareness campaigns, it is also essential to increase access to healthcare
services, particularly in underserved areas. By improving healthcare infrastructure and increasing the
availability of screening and diagnostic tools, we can improve the chances of early detection and
treatment of cervical cancer. Moreover, vaccination against HPV can play a crucial role in preventing the
spread of the virus and reducing the incidence of cervical cancer. Therefore, it is important to increase
vaccination rates among women in India, particularly in rural and low-income areas, where access to
healthcare services may be limited.

I: From your experience, what cultural attitudes and beliefs have you observed among patients regarding
the cervical cancer vaccine in India or a matter of fact regarding HPV in general?
P: In my experience, cultural attitudes and beliefs regarding the cervical cancer vaccine and HPV in India
can vary significantly depending on the patient's background and level of education. While some patients
may be receptive to the vaccine and take proactive steps to protect themselves against HPV, others may
have reservations due to cultural or religious beliefs. For example, some patients may believe that the
vaccine will promote promiscuity or be against their religious beliefs, leading them to refuse the vaccine.
Others may have misconceptions about the vaccine's safety and effectiveness, leading them to avoid it
altogether. Furthermore, some patients may not be aware of the vaccine's availability or the importance of
getting vaccinated against HPV, while others may not have access to healthcare services, making it
difficult to receive the vaccine. Therefore, it is crucial to address cultural attitudes and beliefs regarding
the cervical cancer vaccine and HPV in India through education and awareness campaigns. By providing
accurate information about the vaccine and its potential health benefits, we can help dispel myths and
misconceptions and encourage patients to take proactive steps to protect themselves against HPV and
cervical cancer. Additionally, improving access to healthcare services and making the vaccine more
readily available can help increase vaccination rates and improve healthcare outcomes for women in
India.

I: What do you think are the major barriers/challenges to cervical cancer vaccine uptake among women in
India, from your experience?
P: There are several barriers to vaccine uptake in India, including a lack of awareness about the vaccine
and its benefits, concerns about safety and side effects, and limited access to healthcare services in some
areas. Healthcare providers can help to overcome these barriers by providing education and information
about the vaccine, addressing any concerns or questions that women may have, and working to improve
access to healthcare services in underserved areas.

I: Can you share any insights or experiences regarding the cost-benefit analysis of investing in cervical
cancer prevention through vaccination compared to treating cervical cancer at later stages?
P: From my experience as a doctor, investing in cervical cancer prevention through vaccination is a
cost-effective strategy compared to treating cervical cancer at later stages. While vaccination may require
an upfront investment, it can help prevent the spread of HPV and reduce the incidence of cervical cancer,
which can lead to significant cost savings in the long run. Treating cervical cancer at later stages can be
costly and may require extensive medical intervention, including surgery, radiation therapy, and
chemotherapy.
P: Also, cervical cancer can have a significant impact on a patient's quality of life and ability to work,
leading to indirect costs such as lost productivity and reduced income. In contrast, investing in cervical
cancer prevention through vaccination can help reduce the incidence of cervical cancer and associated
costs, including medical expenses, lost productivity, and reduced quality of life. Moreover, vaccination
can help prevent the spread of HPV, which can lead to other types of cancer and health complications.
Therefore, a cost-benefit analysis of investing in cervical cancer prevention through vaccination compared
to treating cervical cancer at later stages can demonstrate the significant cost savings associated with
vaccination. By investing in prevention, we can help improve healthcare outcomes for women and reduce
the economic burden of cervical cancer on healthcare systems and society as a whole.

I: From your perspective, what are the primary economic barriers hindering widespread adoption of the
cervical cancer vaccine in India, and how can these barriers be addressed? tertiary hospitals provide at
lower and primary levels affordable cost
P: In my perspective, the primary economic barriers hindering widespread adoption of the cervical cancer
vaccine in India are the high cost of the vaccine and limited access to healthcare services, particularly in
rural and low-income areas. The vaccine can be expensive, making it unaffordable for many women,
particularly those who do not have access to health insurance or government subsidies. Moreover, limited
access to healthcare services, particularly in rural areas, can make it challenging to receive the vaccine
and other preventive measures. The vaccine requires multiple doses, which can be logistically challenging
to administer in areas with limited healthcare infrastructure. To address these barriers, it is crucial to make
the vaccine more affordable and accessible to women in India. This can be done through government
subsidies, and other initiatives that reduce the cost of the vaccine. Additionally, increasing access to
healthcare services, particularly in rural areas, can help improve vaccination rates and reduce the
incidence of cervical cancer.

I:Can you elaborate on this idea more as to how tertiary hospitals can play a crucial role in providing
affordable access to the vaccine at lower and primary levels of healthcare.?
P: Simply by partnering with lower-level healthcare facilities and community-based organizations, tertiary
hospitals can help increase access to the vaccine and other preventive measures, particularly in
underserved areas. Overall, addressing economic barriers to the widespread adoption of the cervical
cancer vaccine in India requires a multi-pronged approach that includes government subsidies and
increased access to healthcare services.
I: What strategies do you think are effective in promoting HPV awareness and cervical cancer vaccine
uptake among the Indian population?
P: One of the most effective strategies to combat the spread of HPV and cervical cancer is to collaborate
with community-based organizations and local leaders to increase awareness about the vaccine and its
importance. Social media and other digital platforms can also be used to reach a wider audience and
provide accurate information about the vaccine. Furthermore, it is crucial to enhance access to healthcare
services in underserved areas and ensure that the vaccine is both available and affordable to all women
who need it.

I: How can healthcare providers work with community-based organizations and other stakeholders to
increase HPV awareness and vaccine uptake in India?
P: Community-based interventions, such as workshops, counseling services, and support groups, can play
a crucial role in increasing awareness and knowledge about vaccines and healthcare services. These
interventions can help address the cultural and social barriers that prevent women from seeking medical
attention, such as religious beliefs, social stigma, and lack of access to healthcare services, leading to
improved healthcare outcomes and a healthier population overall.

I: What are the most effective ways to communicate with women and their families about the importance
of HPV vaccination and cervical cancer prevention?
P: Unfortunately, misinformation regarding vaccines and healthcare services often discourages women
from seeking medical attention, which can contribute to the spread of HPV and other preventable
diseases. Therefore, it is essential to address this issue by providing accurate information and dispelling
myths that may cause women to avoid healthcare services.
In addition, many women are unaware that they have contracted HPV, which can lead to a
delayed diagnosis and treatment. Consequently, it is vital to increase awareness of the virus and its
potential health consequences so that women can take the necessary precautions to protect themselves.

I: What are your recommendations for improving awareness and knowledge related to HPV and cervical
cancer prevention in India among the population? College vaccination like hp vac
P: My recommendations for improving awareness and knowledge related to HPV and cervical cancer
prevention in India among the population include: 1. Education and awareness campaigns: Government
and healthcare organizations can collaborate to organize education and awareness campaigns to increase
knowledge and understanding of HPV and cervical cancer among the population.
These campaigns should provide accurate and reliable information on the causes, symptoms, and
prevention of cervical cancer. 2. College vaccination programs: Vaccination programs can be initiated in
colleges and universities to increase the awareness of HPV and cervical cancer among the youth. This can
be done by collaborating with educational institutions to provide the vaccine at discounted rates or for
free. 3. Mobile health clinics: Mobile health clinics can be set up in rural and remote areas to provide
access to screening and vaccination services for HPV and cervical cancer. This approach can be used to
reach those who live in areas with limited access to healthcare facilities. 4. Public-private partnerships:
Public-private partnerships can be established to increase awareness and knowledge related to HPV and
cervical cancer prevention in India.
I: How can this be used in the Indian context?
P: This can be done by collaborating with private organizations to sponsor education and awareness
campaigns, vaccination drives, and health camps. 5. Community-based interventions: Community-based
interventions can be initiated to increase awareness and knowledge about cervical cancer prevention in
India. This can be achieved through community-based workshops, counseling services, and support
groups. Overall, improving awareness and knowledge related to HPV and cervical cancer prevention in
India requires a multi-pronged approach that includes education and awareness campaigns, college
vaccination programs, mobile health clinics, public-private partnerships, and community-based
interventions. By doing so, we can work towards reducing the incidence of cervical cancer and improving
healthcare outcomes for women in India.

I: It is unfortunate that misinformation regarding vaccines and healthcare services often deters many
women from seeking medical attention. What steps can we take to address this issue, and why do you
think it is happening in the first place?
P: Yeah, it's really frustrating how misinformation around vaccines and healthcare services stops so many
women from getting the medical attention they need. One big issue is all these crazy rumors and taboos
floating around, especially in rural areas but even in cities. People get all worked up about how vaccines
might mess with their reproductive system, but honestly, it's just a bunch of nonsense. So, the first step is
to educate folks and spread awareness about the actual facts. One thing to keep in mind is that the HPV
vaccine mainly targets young girls, which can be a bit of a hurdle in some communities. There's this
whole thing about cultural norms and traditions that make it tough for girls to open up about personal
stuff or even go see a doctor. It's like this cycle, you know? Girls feel shy or scared to talk about sexual
health, which can lead to infections going undetected for ages. And then, bam, you've got a whole mess of
health issues to deal with. But By breaking down these barriers, we can really make a difference. We need
to encourage girls to speak up, let them know it's okay to talk about this stuff, and provide them with the
support and resources they need. And yeah, sure, dealing with genital warts or other symptoms can be
demotivating, but there are ways to manage and treat these things. So, let's bust those myths, get the word
out, and help women take charge of their health. It's time to kick misinformation to the curb and make
sure every woman feels empowered to seek the medical care she deserves.

P: In developing countries, why is HPV such a significant problem, and what can be done to improve
healthcare access and vaccination rates in these areas?
I: In developing countries, HPV is a significant problem due to limited access to healthcare services,
including preventive measures such as vaccination. Therefore, it is critical to implement strategies to
improve healthcare access and increase vaccination rates in these areas. By doing so, we can work toward
reducing the incidence of HPV and cervical cancer and improving healthcare outcomes for women
worldwide. But It's tricky, right? The vaccine is mainly aimed at the younger crowd, but cervical cancer
tends to show up later in life. By then, it's often too late, and HPV can quietly wreak havoc without
showing symptoms until things have gotten pretty serious. But there's hope. We could shake things up
with our vaccination guidelines, maybe start screening folks for HPV after their first sexual encounter and
every three years afterward. Early detection could be a game-changer.
P: Then there's the issue of access and affordability. Not everyone has easy access to vaccines or
check-ups, especially those in rural areas or with limited resources. Education is key too. We've got to
spread the word about vaccines and regular screenings so everyone knows how to protect themselves.It's
not just about following the rules; it's about making sure everyone has the tools they need to stay healthy.
Whether it's more screenings or better access to vaccines, we've got to do whatever it takes to fight
cervical cancer.

I: In your experience, have you observed any disparities in vaccine access based on socio-economic
status, and if so, how do healthcare providers navigate these challenges?
P: In my experience, I've seen firsthand how vaccine access is often limited by the size and resources of
healthcare facilities. It's frustrating to witness how vaccines are predominantly available at larger
hospitals, leaving out smaller clinics and healthcare centers. This discrepancy exacerbates the divide in
vaccine access, with those in rural or underserved areas bearing the brunt of the impact. As healthcare
providers, we're challenged to bridge this gap. We advocate for broader vaccine distribution networks that
include not just big hospitals but also smaller clinics and community health centers. By making vaccines
more accessible at all levels of care, we can ensure that no one is left behind in the fight against
preventable diseases like cervical cancer. It's about leveling the playing field and ensuring that every
individual, regardless of where they live or their socio-economic status, has equal access to life-saving
vaccines.